Innovative VIDAS® immunoassays system designed to answer clinical laboratories needs for automation, traceability, quality and optimized workflow
Asia
Europe, Middle East, Africa
North America
bioMérieux - First-Half 2015 Business Review
17 July, 2015
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like
In the U.S., bioMérieux Introduces New Lyme Disease Diagnostic Tests
23 June, 2015
New VIDAS® Lyme Assays Provide Differential Detection and Allow Classification of the Infection
Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux
22 June, 2015
For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat
bioMérieux 2014 Annual Report
04 June, 2015
2014 has been an important and decisive year for bioMérieux in more ways than one.
bioMérieux Honored to Participate in the White House Forum on Antibiotic Stewardship
01 June, 2015
First White House forum to coordinate solutions to address growing public health crisis of antibiotic and antimicrobial resistance
bioMérieux Launches My Role Matters Initiative to Support the fight against Antimicrobial Resistance
30 May, 2015
New Campaign echoes U.S Administration’s National Strategy for Combating Antibiotic-Resistant Bacteria
bioMérieux Joins with “Step-on-Sepsis” as the Primary Corporate Sponsor of North Carolina’s 5K Walk to Raise Awareness of Sepsis, One of the Leading Causes of Death in the U.S.
01 May, 2015
Stopping sepsis through early diagnosis is a primary corporate goal of bioMérieux, Inc
bioMérieux - First Quarter 2015 Business Review
23 April, 2015
bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2015.